The scientific term for stillbirth is intrauterine fetal demise, denoting the unfortunate event of fetal death within the uterus. This term is commonly applied to miscarriages occurring during or after the twenty weeks of pregnancy. This study aims to assess the safety and efficacy of using a combination of mifepristone and misoprostol versus misoprostol alone for labor induction in cases of intrauterine fetal death. Conducted at the Muslim Maternity and Children’s Hospital in Hyderabad, India, this retrospective study spanned six months. Its objective was to evaluate the safety and efficacy of mifepristone and misoprostol in combination versus misoprostol alone for labor induction in managing intrauterine fetal death. Patients administered the mifepristone and misoprostol combination exhibited a significantly shorter induction-to-delivery interval (5.8 hours) compared to those who received only misoprostol (23.3 hours). These findings suggest that the combination of mifepristone and misoprostol is more effective than misoprostol alone for labor induction in the management of intrauterine fetal death.